Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines

Similar Items

• Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and SAHA in lymphoma cell lines
  od: Valdez, Benigno C., i dr.
  Izdano: (2011)
• Synergistic cytotoxicity of sorafenib with busulfan and nucleoside analogs in human FLT3-ITD-positive acute myeloid leukemia cells
  od: Song, Guiyun, i dr.
  Izdano: (2014)
• Mechanistic studies on the synergistic cytotoxicity of the nucleoside analogs gemcitabine and clofarabine in multiple myeloma: Relevance of p53 and its clinical implications
  od: Valdez, Benigno C., i dr.
  Izdano: (2013)
• The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan
  od: Song, Guiyun, i dr.
  Izdano: (2014)
• The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells
  od: Valdez, Benigno C., i dr.
  Izdano: (2017)